ClinConnect ClinConnect Logo
Search / Trial NCT04604808

Study on the Effects of Hypoparathyroidism on Post-thyroidectomy Health-related Quality of Life (QoL-hPTP)

Launched by FUNDACIÓN DE INVESTIGACIÓN BIOMÉDICA - HOSPITAL UNIVERSITARIO DE LA PRINCESA · Oct 21, 2020

Trial Information

Current as of May 06, 2025

Completed

Keywords

Health Related Quality Of Life Thyroidectomy Postoperative Hypoparathyroidism

ClinConnect Summary

Patients submitted to total thyroidectomy according to clinical practice will be invited to participate in this study. If they accept, they will have to complete three questionaries to evaluate their HRQoL: SF-36, Hospital Anxiety and Depression Scale (HADS) and a specifically designed Likert-type questionary about the intensity of hypoparathyroidism symptoms; the day before the surgery and one week and one month after it. In those cases that develop permanent hypoparathyroidism, an additional evaluation will be done 3, 6, 9 and 12 months after surgery.

Variables:

* Demographic variables:...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients submitted to total thyroidectomy
  • Patients older than 18 yo
  • Patients who accept participating in the study.
  • Patients who, before the surgery, have done a complete laboratory test.
  • Patients followed for at least one month after surgery.
  • Exclusion Criteria:
  • - Patients submitted to a subtotal or completion thyroidectomy

About Fundación De Investigación Biomédica Hospital Universitario De La Princesa

The Fundación de Investigación Biomédica - Hospital Universitario de la Princesa is a leading clinical trial sponsor dedicated to advancing medical research and improving patient care through innovative studies. Affiliated with a prestigious hospital, the foundation focuses on a wide range of biomedical research areas, fostering collaboration among healthcare professionals, researchers, and institutions. By prioritizing ethical standards and scientific rigor, the foundation aims to translate research findings into effective therapies and interventions, ultimately enhancing health outcomes for diverse patient populations.

Locations

Madrid, , Spain

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials